Structure-activity relationships of some selected beta-adrenergic blocking agents--oxidation with N-bromosuccinimide.
A relationship between in vitro rate of oxidation by N-bromosuccinimide (NBS) and the pharmacologic activity (pA2) of different beta-adrenergic blockers for different blocking agent-tissue combinations has been studied. The rates of oxidation of the alcoholic group in the drugs by NBS, as well as their molecular conformations as represented by molecular models, were studied in order to determine requirements for selectivity and potency of action of beta-adrenergic blocking agents. Using data from all 7 drugs studied--both nonselective and selective blocking agents--no significant correlation between pA2 and -log k2 (k2 is the second order rate constant for the oxidative reaction) was found. If data from only the 4 nonselective agents were used (16 drug-tissue combinations), a correlation significant at p less than 0.01 was found. Hypotheses are presented to account for the selective action of some beta-adrenergic blocking agents.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D001974:Bromosuccinimide / Q000378:metabolism*; D002078:Butoxamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000378:metabolism; D007700:Kinetics; D008968:Molecular Conformation; D010869:Pindolol / Q000378:metabolism; D011217:Practolol / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D013015:Sotalol / Q000378:metabolism; D013329:Structure-Activity Relationship; D013388:Succinimides / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D013388:Succinimides; D002078:Butoxamine; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D001974:Bromosuccinimide; D011217:Practolol